| First Author | Flores-Martínez Á | Year | 2024 |
| Journal | Biochim Biophys Acta Mol Basis Dis | Volume | 1871 |
| Issue | 1 | Pages | 167543 |
| PubMed ID | 39428000 | Mgi Jnum | J:358050 |
| Mgi Id | MGI:7779010 | Doi | 10.1016/j.bbadis.2024.167543 |
| Citation | Flores-Martinez A, et al. (2024) Conditional Pten inactivation in pituitary results in sex-specific prolactinoma formation. Biochim Biophys Acta Mol Basis Dis 1871(1):167543 |
| abstractText | Pituitary tumors, including prolactinomas, present significant clinical challenges that require a deeper understanding of their molecular roots for improved diagnostics and therapies. Here, we investigate the role of the phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K) pathway in pituitary tumorigenesis using a mouse model. Conditional knockout of Pten in all pituitary cell lineages resulted in prolactinoma formation exclusively in female mice, demonstrating the critical role of PTEN in pituitary homeostasis. While Pten inactivation induced Akt activation in all pituitary cells, only prolactin-producing cells exhibited tumorigenic changes, suggesting specific cell-type effects. Histological and molecular analyses of prolactinomas revealed similarities with human pituitary tumors, such as decreased vascularization and cell adhesion proteins and increased accumulation of cell cycle proteins. Notably, prolactinomas displayed diminished levels of phosphorylated extracellular signal-regulated kinase (ERK), implicating downregulation of ERK in tumorigenesis. Finally, we analyzed PTEN/PI3K activation in a collection of human pituitary tumors. Overall, our study delineates the intricate interplay between the PTEN and ERK signaling pathways, providing insights into sex-specific mechanisms of pituitary tumorigenesis and potential therapeutic strategies for prolactinomas. |
